Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

Credit Suisse Ups Rite Aid to Outperform

Credit Suisse upgraded Rite Aid (RAD) to outperform from underperform, explaining that a solid turnaround in the company's business could mean upside in the share price.

Analyst Edward Kelly says his analysis indicates that downside is limited in the stock price. He views the risk/reward as extremely attractive. He estimates recovery in Earning Before Interest and Taxes margin to 3.5% from 2.5% currently could result in a $9 to 10 stock price. He's encouraged by Rite Aid's recent pharmacy sales trends and says 2006 guidance appears somewhat conservative. He raises his $3 stock price target to $5.50.

blog comments powered by Disqus